Skip to content

Clinical trials

Phase 3 Uveitis, Intermediate trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uveitis, Intermediate Phase: Phase 3 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20104
20122
20141
20151
20171
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Completed6
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
XOMA (US) LLC3
Clearside Biomedical, Inc.2
Lux Biosciences, Inc.2
EyePoint Pharmaceuticals, Inc.1
Novartis1
Priovant Therapeutics, Inc.1
Texas Retina Associates1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uveitis15
Uveitis, Intermediate15
Uveitis, Posterior15
Panuveitis12
Uveitis, Anterior3
Behcet Syndrome1
Cardiovascular Diseases1
Dermatitis1
Myocardial Infarction1
Psoriasis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.